Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Frontiers in Neurology
|
August 19, 2022
Magnetic Resonance Imaging Findings of Intraspinal Tuberculoma in Children
Yirui Zhou, Yong Qin, Tong Mu, et al.
Journal of Cancer
|
May 16, 2018
PIASy antagonizes Ras-driven NSCLC survival by promoting GATA2 SUMOylation
Bin Chen, Jie Luo, Yirui Zhou, et al.
Immunotherapy
|
August 9, 2021
Anti-PD-1 and regorafenib induce severe multisystem adverse events in microsatellite stability metastatic colorectal cancer: a case report
Yuchen Yang, Lingyan Xu, Danping Wang, et al.
Health Physics
|
March 28, 2014
Gross alpha and beta activity analyses in urine-a routine laboratory method for internal human radioactivity detection
Xiaowen Chen, Luqian Zhao, Hongran Qin, et al.
Neural Networks : the Official Journal of the International Neural Network Society
|
June 5, 2023
Distributional generative adversarial imitation learning with reproducing kernel generalization
Yirui Zhou, Mengxiao Lu, Xiaowei Liu, et al.
Journal of Nanobiotechnology
|
February 15, 2024
Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085
Bingqing Hui, Chenchen Zhou, Yetao Xu, et al.
Cell Death & Disease
|
August 24, 2023
A HER2-targeting antibody-MMAE conjugate RC48 sensitizes immunotherapy in HER2-positive colon cancer by triggering the cGAS-STING pathway
Xiaohan Wu, Lingyan Xu, Xiaofei Li, et al.
European Journal of Medical Research
|
January 6, 2024
Association of body temperature and mortality in critically ill patients: an observational study using two large databases
Daniel J Tan, Jiayang Chen, Yirui Zhou, et al.
Eclinicalmedicine
|
January 1, 2026
Efficiency and safety of sintilimab-based induction therapy in potentially resectable stage III non-small cell lung cancer (LungMate-009): an open-label, phase 2 trial
Tao Ge, Hongyi Zhang, Xinsheng Zhu, et al.
Nature Communications
|
February 24, 2025
Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial
Chengxiang Yi, Dongliang Bian, Jue Wang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Frontiers in Neurology
|
August 19, 2022
Magnetic Resonance Imaging Findings of Intraspinal Tuberculoma in Children
Yirui Zhou, Yong Qin, Tong Mu, et al.
Journal of Cancer
|
May 16, 2018
PIASy antagonizes Ras-driven NSCLC survival by promoting GATA2 SUMOylation
Bin Chen, Jie Luo, Yirui Zhou, et al.
Immunotherapy
|
August 9, 2021
Anti-PD-1 and regorafenib induce severe multisystem adverse events in microsatellite stability metastatic colorectal cancer: a case report
Yuchen Yang, Lingyan Xu, Danping Wang, et al.
Health Physics
|
March 28, 2014
Gross alpha and beta activity analyses in urine-a routine laboratory method for internal human radioactivity detection
Xiaowen Chen, Luqian Zhao, Hongran Qin, et al.
Neural Networks : the Official Journal of the International Neural Network Society
|
June 5, 2023
Distributional generative adversarial imitation learning with reproducing kernel generalization
Yirui Zhou, Mengxiao Lu, Xiaowei Liu, et al.
Journal of Nanobiotechnology
|
February 15, 2024
Exosomes secreted by Fusobacterium nucleatum-infected colon cancer cells transmit resistance to oxaliplatin and 5-FU by delivering hsa_circ_0004085
Bingqing Hui, Chenchen Zhou, Yetao Xu, et al.
Cell Death & Disease
|
August 24, 2023
A HER2-targeting antibody-MMAE conjugate RC48 sensitizes immunotherapy in HER2-positive colon cancer by triggering the cGAS-STING pathway
Xiaohan Wu, Lingyan Xu, Xiaofei Li, et al.
European Journal of Medical Research
|
January 6, 2024
Association of body temperature and mortality in critically ill patients: an observational study using two large databases
Daniel J Tan, Jiayang Chen, Yirui Zhou, et al.
Eclinicalmedicine
|
January 1, 2026
Efficiency and safety of sintilimab-based induction therapy in potentially resectable stage III non-small cell lung cancer (LungMate-009): an open-label, phase 2 trial
Tao Ge, Hongyi Zhang, Xinsheng Zhu, et al.
Nature Communications
|
February 24, 2025
Anti-PD1 based precision induction therapy in unresectable stage III non-small cell lung cancer: a phase II umbrella clinical trial
Chengxiang Yi, Dongliang Bian, Jue Wang, et al.
Page
of 2